AstraZeneca Licenses Data from Genaissance s STRENGTH Statin Study | GenomeWeb

NEW YORK, Sept. 11 (GenomeWeb News) - AstraZeneca has licensed data from Genaissance Pharmaceutical's so-called STRENGTH study, the company said today.

Terms of the agreement call for AstraZeneca to receive non-exclusive access to the database, which it will use for "a limited period."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.